Suppr超能文献

含苯磺酰胺基团的硒唑类化合物对细菌 α-、β-和 γ-碳酸酐酶的抑制作用。

Inhibition of bacterial α-, β- and γ-class carbonic anhydrases with selenazoles incorporating benzenesulfonamide moieties.

机构信息

a Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche , Università degli Studi di Firenze , Florence , Italy.

b Centre of Advanced Research in Bionanoconjugates and Biopolymers Department , " Petru Poni" Institute of Macromolecular Chemistry , Iasi , Romania.

出版信息

J Enzyme Inhib Med Chem. 2019 Dec;34(1):244-249. doi: 10.1080/14756366.2018.1547287.

Abstract

A series of benzenesulfonamides incorporating selenazoles with diverse substitution patterns were investigated as inhibitors of six bacterial carbonic anhydrases (CAs, EC 4.2.1.1) from bacterial pathogens, such as Helicobacter pylori (hpCAα was the investigated enzyme), Vibrio cholerae (all the three CAs from this pathogen were considered, VchCAα, VchCAβ and VchCAγ) and Burkholderia pseudomallei (with its two CAs, BpsCAβ and BpsCAγ). All these sulfonamides were effective CA inhibitors, with potencies in the low micromolar or submicromolar range, making them attractive as lead compounds for designing antibacterials with a novel mechanism of action, which could counteract the extensive resistance problem observed with many clinically used antibiotics.

摘要

研究了一系列苯磺酰胺类化合物,其中包含具有不同取代模式的硒唑,作为来自细菌病原体的六种碳酸酐酶(CA,EC 4.2.1.1)的抑制剂,如幽门螺杆菌(hpCAα是研究的酶)、霍乱弧菌(来自该病原体的所有三种 CA,VchCAα、VchCAβ 和 VchCAγ)和类鼻疽伯克霍尔德菌(其两种 CA,BpsCAβ 和 BpsCAγ)。所有这些磺胺类药物都是有效的 CA 抑制剂,其效力在低微摩尔或亚微摩尔范围内,使它们成为设计具有新型作用机制的抗菌药物的有吸引力的先导化合物,可以对抗许多临床使用的抗生素广泛存在的耐药问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba5/6327980/ca0ac4b6c8a1/IENZ_A_1547287_F0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验